Fluorometholone Acetate/Tobramycin

醋酸氟米龙/妥布霉素

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFluorometholone Acetate/Tobramycin
Drug Alias Name妥布霉素/醋酸氟米龙Tobramycin/Fluorometholone Acetatefluorometholone acetate and tobramycintobramycin and fluorometholone acetateTobrasone
ClassificationSmall molecules
Mechanisms of Action30S ribosomal subunit inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor30S ribosomal subunit
Therapy Area/IndicationsEye Infections
Global Approved IndicationsEye Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1989/07/21
Country/TerritoryUnited States
CombinationsYes TobramycinFluorometholone Acetate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarrow Eye LLC
Active IndicationsN/A
Inactive IndicationsEye Infections

Other Information

ATC CodeD07CB03S01CA07
Related LinksN/A